PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Paracetamol - Pyrexia

PAD Profile : Paracetamol - Pyrexia

Traffic Light Status

Status 1 of 4.

Status :
Green
Preferred
Formulations :
  • Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 4.

Status :
Green (see narrative)
Important
Formulations :
  • Effervescent tablets
  • Soluble tablets
  • Suppositories
Important Information :
Reserve for patients who cannot swallow solid dose forms. Soluble / effervescent preparations have a high sodium content and more expensive than ordinary tablets.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 3 of 4.

Status :
Green (see narrative)
Important
Formulations :
  • Oral suspension
Important Information :
120mg/5ml and 250mg/5ml reserved for patients who cannot swallow solid dose forms. Non-formulary: Paracetamol oral suspension 500mg/5ml. Much more expensive. Use a soluble formulation.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 4 of 4.

Status :
Red
Important
Formulations :
  • Injection
Important Information :
Prescribe in milligrams for doses <1g Review infusion prescriptions after 48-72 hours. Note risk of overdose with IV paracetamol.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
SA
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

No committee recommendations returned.

Associated BNF Codes

04. Central Nervous System
04.07.01. Non-opioid analgesics and compound preparations
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More